CTLA4 as Immunological Checkpoint in the Development of Multiple

4.6 (530) ·

$ 0.99 ·

In stock

Description

Mechanism of immune checkpoint blockade through CTLA-4 and PD-L1

FDA-approved classes of immune checkpoint inhibitors (CPIs). CTLA

Antibody Engineering, Review

Immune Checkpoint Inhibitor Therapy in Oncology: Current Uses and

Cardiovascular complications of immune checkpoint inhibitors, TILs

What's Next for Immune Checkpoint Inhibitors: TIM-3?

What is Immune Checkpoint

Pharmaceuticals, Free Full-Text

Make it a double: bispecific antibodies targeting PD-1 and CTLA-4

Frontiers Combining Immune Checkpoint Inhibitors: Established

Immune checkpoint assays

Future prospects of immune checkpoint blockade in cancer: from

Endocrine complications of immunotherapies: a review

Emerging resistance vs. losing response to immune check point